Hinge Health, Inc. is trading at $65.75 (up 4.4%), extending a strong multi-day rally driven by a new share repurchase program and a wave of positive analyst coverage.
- Needham recently named the company its top health tech pick for 2026, while Truist reiterated a Buy rating following a $250 million share repurchase authorization.
- Sentiment remains high as Zacks highlights surging earnings estimates as a primary driver for the stock's current upside potential.